Innovation1 Biotech Inc.
IVBTOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$4494
P/E Ratio—
52W High$0.005
52W Low$0.0002
Innovation1 Biotech Inc. (IVBT) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · IVBT · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-08 | 2022-08 | 2021-08 | 2020-08 | 2019-08 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | ($0.00B) | $0.00B | ($0.00B) | ($0.00B) |
| Gross Margin %(computed) | — | — | 53.86% | -150.97% | -63.21% |
| Operating Expenses | |||||
| R&D Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.01B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — | — | — | -791.21% |
| Interest Income | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.01B) | ($0.04B) | $0.00B | ($0.00B) | ($0.00B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.01B) | ($0.04B) | $0.00B | ($0.00B) | ($0.00B) |
| Net Margin %(computed) | — | — | — | — | -214.52% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.70 | $-2.73 | $5.53 | $-8.59 | $-0.39 |
| Wtd Avg Shares | 0.02B | 0.02B | 0.00B | 0.00B | 0.00B |
| EBITDA | ($0.01B) | ($0.04B) | $0.00B | ($0.00B) | ($0.00B) |
| EBITDA Margin %(computed) | — | — | — | — | -212.00% |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Innovation1 Biotech Inc. data
About Innovation1 Biotech Inc. (IVBT) Income Statement
Innovation1 Biotech Inc. (IVBT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, IVBT reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.01B) — a net profit margin of —.
Frequently asked questions
IVBT · 4 questionsInnovation1 Biotech Inc. (IVBT) reported revenue of $0.00B for 2023, down —% year-over-year.
IVBT revenueIVBT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08